These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37009898)

  • 1. Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation.
    Cui D; Li J; Zhu Z; Berk M; Hardaway A; McManus J; Chung YM; Alyamani M; Valle S; Tiwari R; Han B; Goudarzi M; Willard B; Sharifi N
    J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 37009898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation.
    Hettel D; Zhang A; Alyamani M; Berk M; Sharifi N
    Endocrinology; 2018 Aug; 159(8):2884-2890. PubMed ID: 29850791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer.
    Ganguly S; Lone Z; Muskara A; Imamura J; Hardaway A; Patel M; Berk M; Smile TD; Davicioni E; Stephans KL; Ciezki J; Weight CJ; Gupta S; Reddy CA; Tendulkar RD; Chakraborty AA; Klein EA; Sharifi N; Mian OY
    J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37966114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMX controls 3βHSD1 and sex steroid biosynthesis in cancer.
    Li X; Berk M; Goins C; Alyamani M; Chung YM; Wang C; Patel M; Rathi N; Zhu Z; Willard B; Stauffer S; Klein E; Sharifi N
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hypoxia stabilizes 3βHSD1 via autophagy suppression.
    Qin L; Berk M; Chung YM; Cui D; Zhu Z; Chakraborty AA; Sharifi N
    Cell Rep; 2024 Jan; 43(1):113575. PubMed ID: 38181788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phosphorylation switch controls androgen biosynthesis in prostate cancer.
    Qiu Y
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer.
    Almassi N; Reichard C; Li J; Russell C; Perry J; Ryan CJ; Friedlander T; Sharifi N
    JAMA Oncol; 2018 Apr; 4(4):554-557. PubMed ID: 29049452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer.
    Qin L; Chung YM; Berk M; Naelitz B; Zhu Z; Klein E; Chakraborty AA; Sharifi N
    Cancer Res; 2022 Jul; 82(13):2417-2430. PubMed ID: 35536859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.
    Alyamani M; Emamekhoo H; Park S; Taylor J; Almassi N; Upadhyay S; Tyler A; Berk MP; Hu B; Hwang TH; Figg WD; Peer CJ; Chien C; Koshkin VS; Mendiratta P; Grivas P; Rini B; Garcia J; Auchus RJ; Sharifi N
    J Clin Invest; 2018 Aug; 128(8):3333-3340. PubMed ID: 29939161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.
    Yenki P; Bhasin S; Liu L; Nabavi N; Cheng CW; Tam KJ; Peacock JW; Adomat HH; Tombe T; Fazli L; Ivanova L; Dusek C; Khosravi S; Guns EST; Wang Y; Buttyan R; Gleave ME; Ong CJ
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37800655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer.
    Wu G; Huang S; Nastiuk KL; Li J; Gu J; Wu M; Zhang Q; Lin H; Wu D
    Prostate; 2015 May; 75(7):777-782. PubMed ID: 25731771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer.
    Mostaghel EA; Zhang A; Hernandez S; Marck BT; Zhang X; Tamae D; Biehl HE; Tretiakova M; Bartlett J; Burns J; Dumpit R; Ang L; Matsumoto AM; Penning TM; Balk SP; Morrissey C; Corey E; True LD; Nelson PS
    Clin Cancer Res; 2019 Jan; 25(1):426-439. PubMed ID: 30181386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor.
    Patki M; Huang Y; Ratnam M
    Biochem Biophys Res Commun; 2016 Jul; 476(2):69-74. PubMed ID: 27179779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
    Moll JM; Hofland J; Teubel WJ; de Ridder CMA; Taylor AE; Graeser R; Arlt W; Jenster GW; van Weerden WM
    Prostate; 2022 Apr; 82(5):505-516. PubMed ID: 35037287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer.
    Hahn AW; Gill DM; Nussenzveig RH; Poole A; Farnham J; Cannon-Albright L; Agarwal N
    Clin Genitourin Cancer; 2018 Aug; 16(4):288-292. PubMed ID: 29674118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.
    Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL
    Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.
    Chen L; Wang YY; Li D; Wang C; Wang SY; Shao SH; Zhu ZY; Zhao J; Zhang Y; Ruan Y; Han BM; Xia SJ; Jiang CY; Zhao FJ
    Cancer Lett; 2021 Apr; 503():138-150. PubMed ID: 33503448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cancer-associated fibroblasts with stable markers post-androgen deprivation therapy associated with tumor progression and castration resistant prostate cancer.
    Pan S; Yin R; Zhu H; Shen S; Li Z; Liu B
    Cancer Sci; 2024 Sep; 115(9):2893-2907. PubMed ID: 38970292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.
    Xiao L; Wang Y; Xu K; Hu H; Xu Z; Wu D; Wang Z; You W; Ng CF; Yu S; Chan FL
    Cancer Res; 2018 May; 78(9):2205-2218. PubMed ID: 29438990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.